
INFU
USDInfuSystems Holdings Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$9.250
Kõrge
$9.700
Madal
$8.590
Maht
0.35M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
193.2M
Tööstusharu
Medical Instruments & Supplies
Riik
United States
Kauplemisstatistika
Keskmine maht
0.27M
Börs
ASE
Valuuta
USD
52 nädala vahemik
Tehisintellekti analüüsiaruanne
Viimati uuendatud: 30. okt 2025INFU Stock Analysis: Navigating InfuSystems' Path to Potential Gains
Market Pulse: Recent Price Action
InfuSystems Holdings (INFU) has seen its share price travel quite a journey over the past three months. The stock started this period around $5.70 in late July before shooting up dramatically to peak at $11.04 by late August. Since that high point, we've watched it settle into a more stable range between $9.00 and $11.00.
Right now, INFU is trading near the upper end of its recent range at $10.52 (as of October 29). The path hasn't been smooth--there was a sharp dip in early October that took the price down to around $9.00 before it bounced back. What stands out is how trading volume surged during that August run-up, hitting over 700,000 shares at its peak, compared to the more typical 150,000-250,000 range we've seen lately.
The stock's current position shows it's holding above the $10 mark with some strength. Recent price action suggests buyers are stepping in whenever the stock approaches the lower end of its trading range. This pattern tells us the market isn't ready to let INFU slip back toward those early October lows just yet.
News Context: What's Moving the Needle
The most recent development comes straight from the company's announcement that they'll report third-quarter financial results on November 4, with an investor call scheduled for 9:00 a.m. Eastern Time. This timing explains some of the recent price movement--markets often get active ahead of earnings reports as traders position themselves.
While there's only one news item in our data feed, the system flags this as highly positive sentiment. The upcoming earnings report creates natural anticipation. Healthcare stocks often see increased volatility around earnings season, especially smaller players like INFU with a market cap of just $215 million.
Looking Ahead: The Roadmap
Here's what the coming days might hold based on available signals:
The AI model points to modest upward movement over the next three trading days--roughly 0.9% tomorrow, 2.6% the day after, and nearly 3% by day three. These aren't huge jumps, but they suggest a gradual climb rather than a sudden spike.
Technical indicators paint a mixed picture. On one hand, the DMI reading shows buying pressure outweighing selling pressure (PDI 12.6 versus MDI 8.4).
Seotud uudised
InfuSystem Reports Third Quarter 2025 Financial Results
Record Net Revenues of $36.5 million Representing 3% Growth from the Prior Year Net income of $2.3 million, up 25% Adjusted EBITDA (non-GAAP) of $8.3 million, up 6% Adjusted EBITDA (non-GAAP) margin expanded by 0.5% to
InfuSystem to Report Third Quarter 2025 Financial Results on November 4, 2025
Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for
Tehisintellekti ennustusBeta
Tehisintellekti soovitus
Uuendatud kell: 5. nov 2025, 08:22
67.2% Kindlus
Risk ja kauplemine
Sisenemispunkt
$10.38
Võta kasum
$10.54
Peata kahjum
$9.30
Põhitegurid
Seotud aktsiad
HII
Huntington Ingalls Industries Inc.
GCV
Gabelli Convertible and Income Securities Fund Inc. (The)
HCVIW
Hennessy Capital Investment Corp. VI Warrant
PWSC
PowerSchool Holdings Inc.
CHDN
Churchill Downs Incorporated
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.